HIGHLIGHTS
- who: Hongting Wang from the StJohn`s University, United States have published the research: ERBB2 promoter demethylation and immune cell infiltration promote a poor prognosis for cancer patients, in the Journal: (JOURNAL)
- what: The authors analyzed the distribution of the ERBB2 gene in various types of tumor populations and comprehensively explored the connections between ERBB2 copy number and clinicopathological characteristics. This study provided novel insights that link immune cell infiltration and ERBB2 promoter demethylationrelated signatures to patient survival.
- how: The results showed that a number of normal human tissues have a wide distribution . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.